申请人:Kawamoto Hiroshi
公开号:US20070191389A1
公开(公告)日:2007-08-16
The present invention relates to a compound represented by the formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
R
1
is a linear or branched alkoxy group, a cycloalkoxy group, a linear or branched lower alkyl group, etc.; R
2
is halogen atom, a lower alkyl group, etc.; Q
1
is carbon atom or nitrogen atom; Q
2
is carbon atom which may be substituted with oxo group; the formula (III):
(II)
is a single bond or a double bond; A is a group selected from the group consisting of the substitutent group α; and R
5
is hydrogen atom, a lower alkyl group, cyano group, an alkoxy group or a trialkylsilyl group; having an mGluR1 inhibiting action and being useful as treatment and/or prevention of convulsion, acute pain, cerebral disturbance such as cerebral infarction or transient cerebral ischemia onset, anxiety, chemical dependency or Parkinson's disease.
本发明涉及一种由以下式(I)表示的化合物或其药学上可接受的盐,其中:
R1是线性或支链烷氧基,环烷氧基,线性或支链低烷基等;
R2是卤素原子,低烷基等;
Q1是碳原子或氮原子;
Q2是可能被氧代基取代的碳原子;
式(III):
(II)是单键或双键;
A是从取代基α组成的组中选择的一组;以及
R5是氢原子,低烷基,氰基,烷氧基或三烷基硅基;
具有mGluR1抑制作用,可用于治疗和/或预防抽搐,急性疼痛,脑功能障碍,如脑梗死或短暂性脑缺血发作,焦虑,化学依赖或帕金森病。